Delisting riskPopularity #4,449
Accuray (ARAY)
Builds radiation-treatment systems, planning software, and services around the CyberKnife and TomoTherapy platforms.
$0.2290
vs last close−0.00 (−0.43%)
Something off on this page? Send us feedback.
13F · 13D/G · Form 4
| Institutions | 59.76% | 71.38M shares | |
|---|---|---|---|
| 111 holders · as of Jun 30, 2026 | |||
| Insiders | 4.30% | 5.13M shares | |
| 16 holders · as of Apr 1, 2026 | |||
| Other | 35.94% | 42.93M shares | |
| remainder | |||
119.44M company shares as of Sep 23, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
13F, as of Jun 30, 2026
111 holders · 71.38M shares · 26 new positions · 61 increased · 29 reduced · 41 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| TCW Group Inc | 18.94M | 15.86% | +3.47M | Aug 3, 2026 |
| Neuberger Berman Group LLC | 6.07M | 5.09% | +218.6K | Aug 13, 2026 |
| Armistice Capital, LLC | 5.74M | 4.80% | +100.0K | Aug 14, 2026 |
| Weber Capital Management LLC /Adv | 4.93M | 4.13% | −122.6K | Aug 13, 2026 |
| Vanguard Capital Management LLC | 4.44M | 3.72% | +7.4K | Aug 13, 2026 |
| BlackRock, Inc. | 3.27M | 2.73% | −5.19M | Aug 7, 2026 |
| AQR Capital Management LLC | 2.72M | 2.28% | +2.10M | Aug 14, 2026 |
| Jane Street Group, LLC | 2.14M | 1.79% | +2.14M | Aug 14, 2026 |
13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| The TCW Group, Inc., on behalf of the TCW Business Unit | 18.70% | 27.53M | 13D | Sep 2, 2026 |
| BlackRock, Inc. | 6.50% | 6.72M | 13G | Apr 17, 2025 |
| Neuberger Berman Group LLC | 5.10% | 6.07M | 13G | Jul 7, 2026 |
Form 4
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Feb 20, 2026 | Steven F. Mayerdirector | Purchase | 54,875 | $0.5627 | 1,545,620 |
| Feb 18, 2026 | Steven F. Mayerdirector | Purchase | 126,125 | $0.5328 | 1,421,745 |
| Feb 19, 2026 | Steven F. Mayerdirector | Purchase | 69,000 | $0.5304 | 1,490,745 |
| Nov 19, 2025 | Stephen R. la Nevedirector, officer: CEO | Purchase | 20,000 | $0.9705 | 20,000 |
House and Senate disclosures
Not reported.